We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
New rules from U.S. Treasury Department that reduce incentives for U.S. companies to incorporate overseas have thrown uncertainty into Medtronic’s planned merger with Ireland’s Covidien, and could make the deal less sweet. Read More